Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2007-2-26
pubmed:abstractText
Sleep apnoea syndrome (SAS) is common in acromegaly and both diseases are independently associated with hypertension and insulin resistance contributing to increased morbidity and mortality. Pituitary surgery remains the principal treatment modality in acromegaly. The aim of this study was to assess the prevalence and risk factors of SAS in acromegaly and to analyze the effect of transsphenoidal adenomectomy on SAS and cardiovascular risk factors.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
0804-4643
pubmed:author
pubmed:issnType
Print
pubmed:volume
156
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
321-9
pubmed:meshHeading
pubmed-meshheading:17322492-Acromegaly, pubmed-meshheading:17322492-Adult, pubmed-meshheading:17322492-Aged, pubmed-meshheading:17322492-Blood Glucose, pubmed-meshheading:17322492-Cardiovascular Diseases, pubmed-meshheading:17322492-Female, pubmed-meshheading:17322492-Human Growth Hormone, pubmed-meshheading:17322492-Humans, pubmed-meshheading:17322492-Insulin-Like Growth Factor I, pubmed-meshheading:17322492-Male, pubmed-meshheading:17322492-Middle Aged, pubmed-meshheading:17322492-Neurosurgical Procedures, pubmed-meshheading:17322492-Prospective Studies, pubmed-meshheading:17322492-Risk Factors, pubmed-meshheading:17322492-Sleep, pubmed-meshheading:17322492-Sleep Apnea Syndromes, pubmed-meshheading:17322492-Sphenoid Bone, pubmed-meshheading:17322492-Time Factors, pubmed-meshheading:17322492-Treatment Outcome
pubmed:year
2007
pubmed:articleTitle
Effect of transsphenoidal surgery on sleep apnoea in acromegaly.
pubmed:affiliation
Division of Endocrinology and Diabetes, Department of Internal Medicine, Kantonsspital St Gallen, 9007 St Gallen, Switzerland. lisa.sze@bluewin.ch
pubmed:publicationType
Journal Article, Clinical Trial, Research Support, Non-U.S. Gov't